Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor <scp>XMU‐MP‐1,</scp> protects the heart against adverse effects during pressure overload
Efta Triastuti(University of Brawijaya), Delvac Oceandy(Manchester Academic Health Science Centre)
Cited by 94
Related Papers
Gender-specific accuracy of lipid accumulation product index for the screening of metabolic syndrome in general adults: a meta-analysis and comparative analysis with other adiposity indicators
|Lipids in Health and Disease|2024|36
The Role of Plasma Interleukin-6 Levels on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk Scores in Javanese Patients with Chronic Kidney Disease
|Journal of Personalized Medicine|2022|16